Gujarat Themis Biosyn Quarterly Results for Trading Insights
GUJTHEM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹49 Cr
QMarch 2025
Gujarat Themis Biosyn Quarterly Results Key Highlights
- Revenue of ₹153 Cr in March 2025 (+0.0% vs March 2025, -12.1% vs March 2024)
- Net Profit of ₹49 Cr in March 2025 (+0.0% vs March 2025, -16.9% vs March 2024)
- EBITDA of ₹71 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 46.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹4.48 in March 2025 (+0.0% vs March 2025)
Gujarat Themis Biosyn Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 158 | 153 | 174 | 155 | 119 | 3.3% | - |
| Net Profit (₹ Cr) | 48 | 49 | 59 | 58 | 44 | - | - |
| EBITDA (₹ Cr) | 73 | 71 | 83 | 80 | 62 | - | - |
| EPS (₹) | 4.40 | 4.48 | 40.72 | 39.90 | 30.03 | - | - |
| Operating Margin (%) | 45.0% | 46.0% | 46.0% | 50.0% | 51.0% | - | - |
Gujarat Themis Biosyn Share Price Trend Around Quarterly Results
Visualize Gujarat Themis Biosyn's 1-year price movement across quarterly results — ideal for logging trades in Gujarat Themis Biosyn share price
chart using Tickjournal. All values in ₹.
Related Pages for Gujarat Themis Biosyn
Additional stock information and data for GUJTHEM
Revenue Trend (₹ Cr)
March 2023
155
March 2024
174
March 2025
153
2026
158
Net Profit Trend (₹ Cr)
March 2023
58
March 2024
59
March 2025
49
2026
48
Operating Margin Trend (%)
March 2023
50.0%
March 2024
46.0%
March 2025
46.0%
2026
45.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Gujarat Themis Biosyn quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores